Journals / Gazi Medical Journal / 2018 / Cilt: 29 - Sayı: 2

Term Bir Yenidoğanda Rekombinan Doku Plazminojen Aktivatörü ile Başarı ile Tedavi Edilen İnfektif Endokardit Olgusu

Successful Treatment of Infective Endocarditis Vegetation with Recombinant Tissue Plasminogen Activator in a Term Newborn

Pages
146–147
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Herein we report the use of recombinant tissue plasminogen activator in a term infant to successfully treat a Staphylococcal infective endocarditis vegetation that was unresponsive to antimicrobial therapy and not amenable to surgical therapy

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The development of infective endocarditis and cardiac thrombus is a rare but serious complication in the newborn infant.
📊
Key Findings & Data:The development of infective endocarditis and cardiac thrombus is a rare but serious complication in the newborn infant.
💡
Conclusion & Impact:Herein we report the use of recombinant tissue plasminogen activator in a term infant to successfully treat a Staphylococcal infective endocarditis vegetation that was unresponsive to antimicrobial therapy and not amenable to surgical therapy
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

The development of infective endocarditis and cardiac thrombus is a rare but serious complication in the newborn infant. Herein we report the use of recombinant tissue plasminogen activator in a term infant to successfully treat a Staphylococcal infective endocarditis vegetation that was unresponsive to antimicrobial therapy and not amenable to surgical therapy

Özet

Yenidoğanda enfektif endokardit ve kardiyak tromboz gelişimi, nadir ancak ciddi bir komplikasyondur. Burada rekombinan doku plazminojen aktivatörü kullanılarak başarı ile tedavi edilen antimikrobiyal tedaviye yanıt vermeyen ve cerrahi tedaviye uygun olmayan bir Stafilokokkal infektif endokardit olgusu sunulmuştur

🔖

Cite This Article

DİZDAR, E. A., CETİNKAYA, A. K., UNSAL, H. A., KUTMAN, H. G. K., YARCİ, E., SARİ, F. N., OGUZ, S. S. (2022). Term Bir Yenidoğanda Rekombinan Doku Plazminojen Aktivatörü ile Başarı ile Tedavi Edilen İnfektif Endokardit Olgusu. Gazi Medical Journal, Cilt: 29 - Sayı: 2, 146–147. https://ajindex.com/articles/519807

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Anderson B, Urs P, Tudehope D, Ward C. The use of recombinant tissue plasminogen activator in the management of infective intracardiac thrombi in pre-term infants with thrombocytopaenia.Journal of Paediatrics and Child Health 2009;45:598–601
  2. Saiman L, Prince A, Gersony WM. Pediatric infective endocarditis in the modern era. J Pediatr 1993;122:847-53
  3. Stull TL, Lipuma JJ. (1992) Endocarditis in children. In: Kaye D (ed). Infective endocarditis. 2nd ed. New York, Raven Press, p.313-27
  4. Fleming RE, Barenkamp SJ, Jureidini SB. Successful treatment of a Staphylococcal endocarditis vegetation with tissue plasminogen activator. J. Pediatr. 1998; 132: 535–7
  5. Dajami AS, Taubert KA. (2001) Infected endocarditis in: Moss AJ, Adams FH, editors. Heart disease in infants, children and adolescents. 6th ed, vol 2. Philadelphia (PA): Lippincott Williams & Wilkins;. p.1297-1308
  6. Douglas JL, Dismukes WE. (1992) Surgical therapy of infective endocarditis on natural valves. In: Kaye D (ed). Infective endocarditis. 2nd ed. New York (NY): Raven Press; p. 397
  7. Nomura F, Penny DJ. Surgical intervention for infective endocarditis in infancy and childhood. Ann. Thorac. Surg. 1995; 60: 90–5
  8. Leaker M, Massicotte P, Brokker LA, Andrew M. Thrombolytic therapy in pediatric patients: a comprehensive review of the literature. Thromb Haemost 1996;76:132-4
  9. Nowak-Goth U, Auberger K, Halimeh S. Thrombolysis in newborns and infants. Thromb. Haemost. 1999; 82: 112–6.